In the pharmaceutical industry, Tranexamic Acid 500 mg is a potent antifibrinolytic agent. As a pharmacist and manufacturer, I classify this as a “clot stabilizer.” Unlike anticoagulants (blood thinners), Tranexamic Acid works to prevent the breakdown of blood clots, making it a critical essential medicine for managing various bleeding disorders.
Primary Clinical Uses
Heavy Menstrual Bleeding (Menorrhagia): One of the most common outpatient uses for the 500 mg tablet; it significantly reduces blood loss during cycles.
Post-Operative Hemorrhage: Used in major surgeries (orthopedic, cardiac, and gynecological) to reduce the need for blood transfusions.
Epistaxis (Severe Nosebleeds): Administered orally or sometimes used topically to stop persistent nasal bleeding.
Post-Partum Hemorrhage (PPH): A vital drug in maternal health to control bleeding after childbirth.
Trauma Care: Used in emergency medicine to reduce mortality in patients with significant traumatic injury.
Hereditary Angioedema: Used as long-term prophylaxis to prevent swelling attacks.
Dermatology (Off-label): Increasingly used in low doses for the treatment of Melasma, as it inhibits the UV-induced plasminogen activator.
Mechanism of Action: Competitive Inhibition
Tranexamic Acid works by blocking the process that dissolves blood clots.
Lysine Binding Blockade: It is a synthetic derivative of the amino acid lysine. It binds to the lysine-binding sites on plasminogen molecules.
Inhibition of Plasmin: By blocking these sites, it prevents plasminogen from converting into plasmin (the enzyme that eats through clots).
Fibrin Stabilization: Without plasmin, the fibrin mesh that holds a blood clot together remains intact, effectively stopping the bleeding.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your WHO-GMP facility in Mumbai, the 500 mg tablet is a high-demand “Essential Medicine”:
The 500 mg Standard: This is the most versatile strength. In your digital marketing, you can highlight that a 3-tablet dose (1.5g) is the standard therapeutic unit for acute bleeding.
Stability & Bioavailability: Tranexamic acid is highly soluble. At our facility, we ensure strict In-Vitro Dissolution Testing (BP/USP/IP standards) to ensure that your generic version matches the innovator brand (Cyklokapron).
Packaging for Global Trade: Since it is often used in emergency and maternal health kits, we utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb regions.
Dossier Support: This molecule is a top priority for UNICEF, WHO, and Ministry of Health tenders. We provide full CTD/eCTD Dossiers to support your firm in bidding for international government contracts.